Oragenics (OGEN) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

OGEN is expected to report earnings to fall 95.05% to -5 cents per share on May 15

Q1'23

Est.

$-0.05

Q4'22

Beat

by $1.39

Q3'22

Beat

by $0.02

Q2'22

Beat

by $0.01

Q1'22

Missed

by $0.03

The last earnings report on February 17 showed earnings per share of -100 cents, beating the estimate of -240 cents. With 246.91K shares outstanding, the current market capitalization sits at 3.44M.

View a ticker or compare two or three

Compare

OGEN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For OGEN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

1990 Main Street

Phone

+1 813 286-7900

Employees

Web

https://www.oragenics.com